Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.European cell therapy company TiGenix has renewed GMP license and stem cell product manufacturing authorization at its Madrid manufacturing facility.
Subscribe to our email newsletter
The renewal was followed by a cGMP inspection conducted by Spanish health authorities at the manufacturing facility.
TiGenix CTO Wilfried Dalemans said the Madrid GMP facility manufactures high-quality, clinical grade allogeneic stem cell products.
"It is an important stepping stone before we can move to commercial manufacturing at our state-of-the-art, central GMP manufacturing site in Sittard-Geleen, the Netherlands," Dalemans added.